Compound Detail
CHEMBL3188267
CAPMATINIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL3188267 |
| Name | CAPMATINIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LIOLIMKSCNQPLV-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
5
Targets
9
Activities
2
Assay Types
0
PK Parameters
20
Publications
8
Known Names
12
Indications
1
Mechanisms
Molecular Properties
412.4
MW (Da)
3.43
ALogP
6
HBA
1
HBD
85.1
PSA (Ų)
0.49
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2020 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Hepatocyte growth factor receptor inhibitor | INHIBITOR | Hepatocyte growth factor receptor | ✓ | ✓ |
Indications
Neoplasms Neoplasms Carcinoma, Non-Small-Cell Lung Sarcoma Carcinoma, Hepatocellular Kidney Neoplasms Lung Neoplasms Melanoma Melanoma Breast Neoplasms Glioblastoma Liver Diseases
ATC Classification
L01EX17
capmatinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 7 meas. best 9.89
Kd 2 meas. best 9.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Hepatocyte growth factor receptor CHEMBL3717 | IC50 | 9.89 | 9.7675 | 0.1 | 4 |
| Hepatocyte growth factor receptor CHEMBL3717 | Kd | 9.52 | 9.52 | 0.3 | 1 |
| EBC-1 CHEMBL4296411 | IC50 | 8.92 | 8.92 | 1.2 | 1 |
| NCI-H1993 CHEMBL1075527 | IC50 | 8.64 | 8.64 | 2.3 | 1 |
| SNU-5 CHEMBL614934 | IC50 | 8.57 | 8.57 | 2.7 | 1 |
| Cyclin-dependent kinase-like 5 CHEMBL1163112 | Kd | 5.69 | 5.69 | 2042.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 37657268 | 10.1016/j.ejmech.2023.115758 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Beta-adrenergic receptor kinase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Adenosine kinase | 1 |
| 37657268 | 10.1016/j.ejmech.2023.115758 | Spike glycoprotein | 1 |
| 29191878 | 10.1126/science.aan4368 | AarF domain-containing protein kinase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1-like | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-2B | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1B | 1 |
| 29191878 | 10.1126/science.aan4368 | Peroxisomal acyl-coenzyme A oxidase 3 | 1 |
| 29191878 | 10.1126/science.aan4368 | Peroxisomal acyl-coenzyme A oxidase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 11 | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 10 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL2 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL1 | 1 |
Data from ChEMBL 36 via Core Engine